What is a stock summary page? Click here for an overview.
Business Description
SciBase Holding AB
ISIN : SE0007045414
Compare
Compare
Traded in other countries / regions
SCIB.Sweden5J3.Germany IPO Date
2015-06-02Description
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, theĀ United States/North America, and Asia/Oceania.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.59 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -15.42 | |||||
| Beneish M-Score | -0.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.6 | |||||
| 3-Year EBITDA Growth Rate | 17.1 | |||||
| 3-Year EPS without NRI Growth Rate | 19.5 | |||||
| 3-Year FCF Growth Rate | 19.4 | |||||
| 3-Year Book Growth Rate | -45 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 53.73 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.54 | |||||
| 9-Day RSI | 35.61 | |||||
| 14-Day RSI | 41.73 | |||||
| 3-1 Month Momentum % | 10 | |||||
| 6-1 Month Momentum % | -17.23 | |||||
| 12-1 Month Momentum % | 19.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.39 | |||||
| Quick Ratio | 2.03 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 448.27 | |||||
| Days Sales Outstanding | 94.69 | |||||
| Days Payable | 187.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -46 | |||||
| Shareholder Yield % | -31.34 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.96 | |||||
| Operating Margin % | -226.14 | |||||
| Net Margin % | -205.78 | |||||
| FCF Margin % | -193.61 | |||||
| ROE % | -152.86 | |||||
| ROA % | -99.74 | |||||
| ROIC % | -222.62 | |||||
| 3-Year ROIIC % | -100.3 | |||||
| ROC (Joel Greenblatt) % | -590.22 | |||||
| ROCE % | -134.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.29 | |||||
| PB Ratio | 2.25 | |||||
| Price-to-Tangible-Book | 2.21 | |||||
| EV-to-EBIT | -1.73 | |||||
| EV-to-EBITDA | -1.73 | |||||
| EV-to-Revenue | 3.35 | |||||
| EV-to-FCF | -1.85 | |||||
| Price-to-GF-Value | 0.49 | |||||
| Price-to-Median-PS-Value | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 2.68 | |||||
| Earnings Yield (Greenblatt) % | -57.72 | |||||
| FCF Yield % | -45.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
SciBase Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 29.704 | ||
| EPS (TTM) (kr) | -0.33 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -0.98 | ||
| Volatility % | 63.72 | ||
| 14-Day RSI | 41.73 | ||
| 14-Day ATR (kr) | 0.032361 | ||
| 20-Day SMA (kr) | 0.4103 | ||
| 12-1 Month Momentum % | 19.43 | ||
| 52-Week Range (kr) | 0.235 - 0.6 | ||
| Shares Outstanding (Mil) | 338.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SciBase Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SciBase Holding AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
SciBase Holding AB Frequently Asked Questions
What is SciBase Holding AB(OSTO:SCIB)'s stock price today?
The current price of OSTO:SCIB is kr0.38. The 52 week high of OSTO:SCIB is kr0.60 and 52 week low is kr0.24.
When is next earnings date of SciBase Holding AB(OSTO:SCIB)?
The next earnings date of SciBase Holding AB(OSTO:SCIB) is 2025-05-13.
Does SciBase Holding AB(OSTO:SCIB) pay dividends? If so, how much?
SciBase Holding AB(OSTO:SCIB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers